Viragen, Cancer Research Campaign Technology Ltd., University of Nottingham deal

Viragen (Scotland) Ltd., a subsidiary of VRA's Viragen (Europe) Ltd. subsidiary (Penicuick, U.K.), the university and CRCT will develop a cancer vaccine targeting complement inhibitor CD55 to treat b...